FutureWise Research, a leading global market intelligence firm, today released a landmark report on Plasmid DNA Manufacturing ...
Company seeks strategic partners to advance novel PlaCCine technologyLAWRENCEVILLE, N.J., Oct. 17, 2025 (GLOBE NEWSWIRE) -- IMUNON , Inc.
First DNA Cancer Vaccine Commercial Approval Expected By 2030 Says Kuick ResearchDelhi, Oct. 16, 2025 (GLOBE NEWSWIRE) -- ...
Rapid advances in viral vectors, advanced plasmid DNA and oncology drive new expansion in global markets.Austin, Oct. 17, 2025 (GLOBE NEWSWIRE) -- Gene Therapy Starting Materials Market Size & Growth ...
Prestigious European Society for Medical Oncology Conference “trials-in-progress” sessionPivotal OVATION 3 trial of its DNA-mediated ...
Prof. Kabiru Akinyemi of the Department of Microbiology, Faculty of Science, Lagos State University (LASU) has sought the ...
This article outlines common CMC problems that are obstacles that steal momentum and create costly detours in the development ...
The company said the new chemistry could decrease sequencing costs for high-throughput users by up to 40%, lowering the ...
The peer-reviewed publication this week in Nature Publishing Cell Death & Disease(1) provides compelling support for the hypothesis that iron dysregulation is not merely a bystander, but a potential ...
PacBio (NASDAQ: PACB), developer of the world's most advanced sequencing technologies, today announced innovations to its Revio and Vega platforms ...
A clinical study in the United States has begun using a novel form of synthetic DNA as a key ingredient in the manufacture of ...
The Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, Kongens Lyngby, Denmark ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback